Evidence map›Paper›PMID 42434635›Full record

ArticleCureus2026

Fatal Wunderlich Syndrome During Hemodialysis: A Rare Case and Review of the Literature.

Darius Mbina Nzienghi, Liela Agnès Okoyi Ossouka, Yahya Sqalli Houssaini, Said Jidane, Tahir Nebhani, Ahmed Belkouch, Lahcen Belyamani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Darius Mbina NzienghiDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.
Liela Agnès Okoyi OssoukaDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.
Yahya Sqalli HoussainiDepartment of Radiology, Mohammed V Military Training Hospital, Rabat, MAR.
Said JidaneDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.
Tahir NebhaniDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.
Ahmed BelkouchDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.
Lahcen BelyamaniDepartment of Emergency Medicine, Mohammed V Military Training Hospital, Rabat, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wunderlich syndrome (WS) is a rare but life-threatening condition characterized by spontaneous, non-traumatic renal hemorrhage, which may present with Lenk's triad. Early recognition and prompt management are crucial to improve prognosis. We report the case of a 49-year-old man with end-stage renal disease secondary to antineutrophil cytoplasmic antibody-associated vasculitis on maintenance hemodialysis who developed sudden left flank pain during a routine hemodialysis session, without preceding trauma. Laboratory evaluation revealed anemia and elevated international normalized ratio. Computed tomography demonstrated an enlarged left kidney with multiple cystic lesions and a large perirenal hematoma extending into the retroperitoneal space, consistent with WS. Despite initial resuscitative measures, the patient rapidly deteriorated into refractory hemorrhagic shock and died before definitive intervention could be performed. This case highlights the potential for rapid deterioration in hemodialysis patients and underscores the importance of early recognition, rapid imaging, and timely multidisciplinary management.

Indexed as

critical emergency medicinehemodialysislenk’s triadspontaneous renal hemorrhagewunderlich syndrome

Identifiers

PMID42434635
PMCPMC13352129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.